Hervé Prats

7.7k citations
89 papers · 5.8k indexed · h-index 42

Impact in

    • Fibroblast Growth Factor Research
    • RNA and protein synthesis mechanisms
    • RNA Research and Splicing
    • RNA modifications and cancer
    • Angiogenesis and VEGF in Cancer
    • Kruppel-like factors research
    • Proteoglycans and glycosaminoglycans research

Papers in

    • Fibroblast Growth Factor Research 29
    • RNA and protein synthesis mechanisms 18
    • RNA modifications and cancer 16
    • RNA Research and Splicing 16
    • Angiogenesis and VEGF in Cancer 8
    • Cancer-related gene regulation 6
    • Kruppel-like factors research 6
    • Proteoglycans and glycosaminoglycans research 8

Hervé Prats

89 papers receiving 5.7k citations

Peers

Hervé Prats
Comparison fields: 5 of 116
  • Molecular Biology 4.5k
  • Cell Biology 916
  • Cancer Research 770
  • Oncology 749
  • Genetics 730
Replace Phyllis Ponte with:
Phyllis Ponte United States
Jean Marie Blanchard France
Salvatore Oliviero Italy
Stephen A. Liebhaber United States
Marian L. Waterman United States
S Munemitsu United States
S Y Ng United States
Benoı̂t Chabot Canada
Jeff Friedman United States
Xiang‐Fu Wu China
Hervé Prats relative to Phyllis Ponte United States Phyllis Ponte's profile →
Citations per field
00.5×20×40×60×73×
Phyllis Ponte · 1×
Citations per year

Countries citing papers authored by Hervé Prats

Since Specialization
Citations

This map shows the geographic impact of Hervé Prats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Prats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Prats more than expected).

Fields of papers citing papers by Hervé Prats

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Prats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Prats. The network helps show where Hervé Prats may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hervé Prats, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hervé Prats Line = papers co-authored together Hervé Prats links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202111
2 201384
3 201322
4 200916
5 200956
6 200869
7 200639
8 200630
9 200365
10 200245
11 200197
12 20002
13 199960
14 199411
15 199374
16 199224
17 19927
18 199131
19 199183
20 198943

About Hervé Prats

Hervé Prats is a scholar working on Molecular Biology, Cell Biology, Cancer Research, Oncology and Molecular Medicine, having authored 89 papers that have together received 5.8k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (29 papers), RNA and protein synthesis mechanisms (18 papers), RNA modifications and cancer (16 papers), RNA Research and Splicing (16 papers), Angiogenesis and VEGF in Cancer (8 papers), Proteoglycans and glycosaminoglycans research (8 papers), Cancer-related gene regulation (6 papers) and Kruppel-like factors research (6 papers). The work is most often cited by research in Molecular Biology (4.5k citations), Cell Biology (916 citations), Cancer Research (770 citations), Oncology (749 citations) and Genetics (730 citations). Hervé Prats has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Anne‐Catherine Prats, F. Amalric, Christian Touriol, Marie-Claire Gensac, Stéphan Vagner, B. Bugler, François Amalric, J. Tauber, Laurent Créancier and Françis Bayard. Their work appears in journals such as Molecular and Cellular Biology, Journal of Biological Chemistry, Nucleic Acids Research, Proceedings of the National Academy of Sciences and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026